These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9122396)

  • 21. Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation.
    Woo K; Emery J; Peabody J
    Pediatrics; 1994 Mar; 93(3):417-20. PubMed ID: 8115200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soft-tissue swelling in two neonates during prostaglandin E1 therapy.
    Jureidini S; Chase NA; Alpert BS; Vanderzalm T; Sheneflet RE
    Pediatr Cardiol; 1986; 7(3):157-60. PubMed ID: 3543871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications of Long-Term Prostaglandin E1 Use in Newborns With Ductal-Dependent Critical Congenital Heart Disease.
    Alhussin W; Verklan MT
    J Perinat Neonatal Nurs; 2016; 30(1):73-9. PubMed ID: 26813395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nursing care of the neonate receiving prostaglandin E1 therapy.
    Rikard DH
    Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocytosis caused by prostaglandin E1 in neonates.
    Arav-Boger R; Baggett HC; Spevak PJ; Willoughby RE
    J Pediatr; 2001 Feb; 138(2):263-5. PubMed ID: 11174627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supportive and emergency use of prostaglandin in the neonate with congenital heart disease.
    Hussain A; al Khudhairi D
    Middle East J Anaesthesiol; 1993 Feb; 12(1):73-81. PubMed ID: 8316154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT; Norton JB; Readinger RI; Sotomora RF
    J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].
    Fujii S; Nagai I; Yonei A; Sari A; Baba K
    Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818
    [No Abstract]   [Full Text] [Related]  

  • 29. Radiologic features of gastric outlet obstruction in infants after long-term prostaglandin administration.
    Babyn P; Peled N; Manson D; Dagan O; Silver MM; Koren G
    Pediatr Radiol; 1995; 25(1):41-3; discussion 44. PubMed ID: 7761161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of prostaglandin E1 in the treatment of cyanotic congenital heart defects in infants].
    Dymnicka S; Bielińska B; Ereciński J; Machnowski W
    Pediatr Pol; 1981 Oct; 56(10):1243-8. PubMed ID: 7199703
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostaglandin-induced hyperostosis. A case report.
    Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
    Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enteral feeding in neonates with prostaglandin-dependent congenital cardiac disease: international survey on current trends and variations in practice.
    Howley LW; Kaufman J; Wymore E; Thureen P; Magouirk JK; McNair B; da Cruz EM
    Cardiol Young; 2012 Apr; 22(2):121-7. PubMed ID: 21771388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E1 in infants with critical congenital heart disease.
    Dungan WT
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Jan; 1(1):71-4. PubMed ID: 2454319
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
    Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
    J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periosteal reaction induced by prostaglandins.
    Niethammer JG; Rule KA; Lorch V; Anderson ME
    Am J Perinatol; 1992 Jul; 9(4):279-80. PubMed ID: 1627219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plain film and CT observations in prostaglandin-induced bone changes.
    Matzinger MA; Briggs VA; Dunlap HJ; Udjus K; Martin DJ; McDonald P
    Pediatr Radiol; 1992; 22(4):264-6. PubMed ID: 1523047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone and tissue changes following prostaglandin therapy in neonates.
    Kaufman MB; El-Chaar GM
    Ann Pharmacother; 1996 Mar; 30(3):269-74, 277. PubMed ID: 8833563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brown fat necrosis in the setting of congenital heart disease and prostaglandin E1 use: a case report.
    Raboi CA; Smith W
    Pediatr Radiol; 1999 Jan; 29(1):61-3. PubMed ID: 9880620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.